Kansas SB 236: Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.

Status: Died in Committee (as of 2024-04-30)

State: Kansas · Session: 2023-2024 · Bill: SB 236

Sponsors: Committee on Public Health and Welfare

View Kansas SB 236 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.